Adaptin Bio, Inc.
APTN
$6.27
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.17% | 16.22% | 18.36% | -10.17% | -152.18% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | 28.49% | 95.47% | -44.80% | 28.04% | 178.13% |
| Change in Net Operating Assets | 52.30% | -58.15% | -16.24% | 135.03% | 117.59% |
| Cash from Operations | 24.50% | 15.17% | 9.00% | 24.47% | 55.14% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 15.04% | -- | -- | -- | 100.00% |
| Issuance of Common Stock | 42.50% | -34.80% | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 74.17% | 70.94% | -- | -- | 100.00% |
| Cash from Financing | 86.88% | -24.80% | -- | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 333.82% | -31.69% | 84.48% | 24.47% | -143.70% |